Abbott’s STI test gets FDA nod

2020 11 11 19 32 2939 Modern Lab Equipment 400

Abbott announced that it has obtained clearance from the U.S. Food and Drug Administration (FDA) for a diagnostic test that detects four common sexually transmitted infections (STIs).

The Alinity m STI test uses polymerase chain reaction (PCR) to detect Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, and Mycoplasma genitalium. The test requires one swab sample, or a urine sample collected in a healthcare setting, and it runs on Abbott's Alinity m molecular laboratory instrument.

Page 1 of 1